Johnson & Johnson to Acquire Actelion in $30 Billion Deal ... Review
Johnson & Johnson has agreed to acquire Actelion Ltd. for $30 billion, in an unusual deal that will also spin out the Swiss biotech company’s drug-discovery operations.
Johnson & Johnson has agreed to acquire Actelion Ltd. for $30 billion, in an unusual deal that will also spin out the Swiss biotech company’s drug-discovery operations.
Johnson Controls International PLC stock price, stock quotes and financial overviews from MarketWatch.
Read MoreBiotech, clinical research, and pharmaceutical news and jobs as well as industry-renowned Career Fairs in various life science Hotbeds across the U.S.
Read MoreRead the latest biotechnology articles on biotech industry leaders, emerging biotech companies, FDA decisions, VC deals, and other biotech industry news.
Read MoreFor more information on the following and other outboards, call us at 1-800-630-1233. We have an excellent selection of rebuilt Johnson powerheads and lower units.
Read MoreJohnson & Johnson Innovation Announces New Collaborations Advancing Ground-Breaking Biomedical Innovation Around the Globe
Read MoreJohnson Controls is a global diversified technology and multi industrial leader serving a wide range of customers in more than 150 countries.
Read MoreThe New Deal was a series of programs, including, most notably, Social Security, that were enacted in the United States between 1933 and 1938, and a few that came later.
Read MoreJohnson & Johnson stock price, stock quotes and financial overviews from MarketWatch.
Read MoreEndicott Johnson Corporation; Fate: Mostly defunct: Predecessor: Lester Brothers Boot and Shoe Company: Successor: Rocky Shoes and Boots: Founded: 1899: Headquarters
Read More